Bioactivity of enoxaparin in critically ill patients with normal renal function.

about

The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study.[Atrial fibrillation in the ICU. Distinct entity--special treatment?].

P2860

Q37328158-7DB10021-0489-4B2A-80CF-7FDBFE8EFD98 Q45903533-A0E4E786-D057-4F25-B44A-BE90190E2391

P2860

Bioactivity of enoxaparin in critically ill patients with normal renal function.

Item

http://www.wikidata.org/entity/Q36390249

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@ast

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@en

type

Item

label

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@ast

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@en

prefLabel

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@ast

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@en

P1476

Bioactivity of enoxaparin in critically ill patients with normal renal function.

@en

P2093

Alexander Stella

http://www.w3.org/2001/XMLSchema#string

Christian Madl

http://www.w3.org/2001/XMLSchema#string

Ghazaleh Gouya

http://www.w3.org/2001/XMLSchema#string

Gottfried Heinz

http://www.w3.org/2001/XMLSchema#string

Gottfried Locker

http://www.w3.org/2001/XMLSchema#string

Stefan Palkovits

http://www.w3.org/2001/XMLSchema#string

Stylianos Kapiotis

http://www.w3.org/2001/XMLSchema#string

P2860

Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study.

Statistical methods for assessing agreement between two methods of clinical measurement

Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model

Calibrated automated thrombin generation measurement in clotting plasma

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Prediction of creatinine clearance from serum creatinine

[Prevention of thromboembolism in German intensive care units : Results of a nationwide survey].

Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial.

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study.

Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis.

P304

806-814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2012.04285.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Wolzt

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233890109

http://www.w3.org/2001/XMLSchema#string

P698

23227470

http://www.w3.org/2001/XMLSchema#string

P932

3495145

http://www.w3.org/2001/XMLSchema#string

Bioactivity of enoxaparin in critically ill patients with normal renal function.

about

P2860

P2860

Bioactivity of enoxaparin in critically ill patients with normal renal function.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932